TMEM175
Basic information
Region (hg38): 4:932387-958656
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (90 variants)
- not_provided (4 variants)
- TMEM175-related_disorder (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM175 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000032326.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 87 | 92 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 87 | 7 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TMEM175 | protein_coding | protein_coding | ENST00000264771 | 10 | 26270 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.05e-9 | 0.509 | 125553 | 1 | 193 | 125747 | 0.000772 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.555 | 370 | 341 | 1.08 | 0.0000233 | 3217 |
| Missense in Polyphen | 113 | 115.27 | 0.98032 | 1161 | ||
| Synonymous | -1.22 | 184 | 164 | 1.12 | 0.0000125 | 1100 |
| Loss of Function | 1.10 | 16 | 21.5 | 0.745 | 0.00000111 | 207 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00137 | 0.00136 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000763 | 0.000761 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000608 | 0.000598 |
| Middle Eastern | 0.000763 | 0.000761 |
| South Asian | 0.00252 | 0.00249 |
| Other | 0.000829 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Organelle-specific potassium channel specifically responsible for potassium conductance in endosomes and lysosomes. Forms a potassium-permeable leak-like channel, which regulates lumenal pH stability and is required for autophagosome-lysosome fusion. Constitutes the major lysosomal potassium channel. {ECO:0000269|PubMed:26317472, ECO:0000269|PubMed:28723891}.;
- Disease
- DISEASE: Parkinson disease (PARK) [MIM:168600]: A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features. {ECO:0000269|PubMed:28193887}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry. TMEM175 defects result in unstable lysosomal pH, leading to decreased lysosomal catalytic activity, decreased glucocerebrosidase activity, impaired autophagosome clearance by the lysosome and decreased mitochondrial respiration (PubMed:28193887). {ECO:0000269|PubMed:28193887}.;
Intolerance Scores
- loftool
- 0.800
- rvis_EVS
- 0.81
- rvis_percentile_EVS
- 87.74
Haploinsufficiency Scores
- pHI
- 0.168
- hipred
- N
- hipred_score
- 0.318
- ghis
- 0.482
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.248
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmem175
- Phenotype
Gene ontology
- Biological process
- regulation of lysosomal lumen pH;potassium ion transmembrane transport;phagosome-lysosome fusion
- Cellular component
- lysosome;lysosomal membrane;endosome;endosome membrane;integral component of membrane
- Molecular function
- potassium channel activity;potassium ion leak channel activity